NovaBridge Biosciences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
NovaBridge Biosciences (NBP) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $80.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-04-07
CNY
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2023-12-31 | 124.73M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 38.57M CNY 20-F · filed 2024-04-30 |
| 2021-12-31 | 68.40M CNY 20-F · filed 2024-04-30 |
| 2020-12-31 | 72.26M CNY 20-F · filed 2023-05-01 |
| 2019-12-31 | 87.02M CNY 20-F · filed 2022-04-29 |
| 2018-12-31 | 2.55M CNY 20-F · filed 2021-04-28 |
| 2017-12-31 | 3.89M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $80.00K 20-F · filed 2026-04-07 | |
| 2023-12-31 | $9.68M 20-F · filed 2026-04-07 | $17.57M 20-F · filed 2024-04-30 |
| 2022-12-31 | $18.64M 20-F · filed 2025-04-03 | $5.59M 20-F · filed 2023-05-01 |
| 2021-12-31 | $10.73M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $11.07M 20-F · filed 2021-04-28 | |
| 2019-12-31 | $12.50M 20-F · filed 2020-04-29 |